MHRA Update: Regulatory Considerations for the Registration of New Antibacterial Agents
MHRA to provide news updates on regulatory considerations at 20th annual “Superbugs” summit.
London, United Kingdom, December 15, 2017 --(PR.com)-- Taking place in London on 19th and 20th March 2018, the theme for SMi’s 20th annual conference on Superbugs and Superdrugs is to tackle the scientific, regulatory and economic challenges to combat AMR.
Highlights will include an exclusive keynote address from the MHRA when SMi Group welcomes the expertise of Mair Powell to provide regulatory guidance on the registration of new antibacterial agents.
Dr. Powell is a member of the EMA’s Infectious Disease Working Party and was its chair for 6 years. She has been closely involved in all guideline development for anti-infective agents for 20 years and is currently the chair of the EMA’s Vaccine Working Party.
Her unique experience will provide attendees with critical updates on recent policies and planned revisions to EMA guidance. Presentation highlights will include talks surrounding antibacterial agents with the potential to address an unmet need; options for clinical development programmes; and the importance of the pharmacokinetic - pharmacodynamic relationship.
The notable speaker panel will also include talks from TranScrip Partners, Chemical Biology Ventures, Drugs for Neglected Diseases initiative (DNDi), Nemesis Bioscience, Alchemy Biomedical Consulting, ABAC Therapeutics, Oppilotech, Gladius Pharmaceuticals, Pew Charitable Trusts, Blueberry Therapeutics, UNT Health Science Center, ContraFect, SCYNEXIS and more.
SMi’s 20th Annual conference on Superbugs & Superdrugs will take place on 19th & 20th March 2018 at the Copthorne Tara Hotel, Kensington in London, UK.
Further details including a full speaker line-up and detailed programme are available at www.superbugssuperdrugs.com/prcom
For those looking to attend there is currently a £200 early bird saving available until December 15, 2017.
Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.
Highlights will include an exclusive keynote address from the MHRA when SMi Group welcomes the expertise of Mair Powell to provide regulatory guidance on the registration of new antibacterial agents.
Dr. Powell is a member of the EMA’s Infectious Disease Working Party and was its chair for 6 years. She has been closely involved in all guideline development for anti-infective agents for 20 years and is currently the chair of the EMA’s Vaccine Working Party.
Her unique experience will provide attendees with critical updates on recent policies and planned revisions to EMA guidance. Presentation highlights will include talks surrounding antibacterial agents with the potential to address an unmet need; options for clinical development programmes; and the importance of the pharmacokinetic - pharmacodynamic relationship.
The notable speaker panel will also include talks from TranScrip Partners, Chemical Biology Ventures, Drugs for Neglected Diseases initiative (DNDi), Nemesis Bioscience, Alchemy Biomedical Consulting, ABAC Therapeutics, Oppilotech, Gladius Pharmaceuticals, Pew Charitable Trusts, Blueberry Therapeutics, UNT Health Science Center, ContraFect, SCYNEXIS and more.
SMi’s 20th Annual conference on Superbugs & Superdrugs will take place on 19th & 20th March 2018 at the Copthorne Tara Hotel, Kensington in London, UK.
Further details including a full speaker line-up and detailed programme are available at www.superbugssuperdrugs.com/prcom
For those looking to attend there is currently a £200 early bird saving available until December 15, 2017.
Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.
Contact
SMi Group
Teri Arri
+44 (0) 20 7827 6162
http://www.superbugssuperdrugs.com/prcom
Teri Arri
+44 (0) 20 7827 6162
http://www.superbugssuperdrugs.com/prcom
Contact
Categories